Oral Sciences Research Group, Glasgow Dental School, School of Medicine, Dentistry and Nursing, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
Forth Valley Royal Hospital, Larbert, United Kingdom.
Antimicrob Agents Chemother. 2021 May 18;65(6). doi: 10.1128/AAC.02551-20.
Calcium sulfate (CS) has been used clinically as a bone- or void-filling biomaterial, and its resorptive properties have provided the prospect for its use as a release mechanism for local antibiotics to control biofilms. Here, we aimed to test CS beads loaded with three antifungal drugs against planktonic and sessile fungal species to assess whether these antifungal beads could be harnessed to provide consistent release of antifungals at biofilm-inhibitory doses. A panel of different fungal species ( = 15) were selected for planktonic broth microdilution testing with fluconazole (FLZ), amphotericin B (AMB), and caspofungin (CSP). After establishing planktonic inhibition, antifungal CS beads were introduced to fungal biofilms ( = 5) to assess biofilm formation and cell viability through a combination of standard quantitative and qualitative biofilm assays. Inoculation of a hydrogel substrate, packed with antifungal CS beads, was also used to assess diffusion through a semidry material, to mimic active infection In general, antifungals released from loaded CS beads were all effective at inhibiting the pathogenic fungi over 7 days within standard MIC ranges for these fungi. We observed a significant reduction of pregrown fungal biofilms across key fungal pathogens following treatment, with visually observable changes in cell morphology and biofilm coverage provided by scanning electron microscopy. Assessment of biofilm inhibition also revealed reductions in total and viable cells across all organisms tested. These data show that antifungal-loaded CS beads produce a sustained antimicrobial effect that inhibits and kills clinically relevant fungal species as planktonic and biofilm cells.
硫酸钙 (CS) 已在临床上用作骨填充或空洞填充生物材料,其可吸收性为局部抗生素释放机制提供了前景,以控制生物膜。在这里,我们旨在测试载有三种抗真菌药物的 CS 珠粒对浮游和固着真菌物种的作用,以评估这些抗真菌珠粒是否可用于以抑制生物膜的剂量持续释放抗真菌药物。选择了一组不同的真菌物种( = 15)进行氟康唑 (FLZ)、两性霉素 B (AMB) 和卡泊芬净 (CSP) 的浮游肉汤微量稀释测试。在确定浮游抑制作用后,将抗真菌 CS 珠粒引入真菌生物膜( = 5),通过标准定量和定性生物膜测定的组合来评估生物膜形成和细胞活力。还使用载有抗真菌 CS 珠粒的水凝胶基质的接种来评估通过半干燥材料的扩散,以模拟活性感染。通常,负载 CS 珠粒释放的抗真菌药物在标准 MIC 范围内在 7 天内有效抑制致病性真菌。在用药物处理后,我们观察到关键真菌病原体的预生长真菌生物膜显著减少,扫描电子显微镜观察到细胞形态和生物膜覆盖范围的明显变化。生物膜抑制评估还显示所有测试生物的总细胞和活细胞减少。这些数据表明,载有抗真菌药物的 CS 珠粒产生持续的抗菌作用,可抑制和杀死浮游和生物膜细胞中的临床相关真菌物种。